Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Canada’s life sciences firm said H1 revenue increased 23% year-on-year, driven by new hospital deployments and higher utilisation. Operating loss widened due to higher R&D spend for its LANTERN Phase 3 trial; sales and marketing expenses were held flat.
OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.(This story was created using…